Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marrow Transplantation for Chronic Lymphocytic Leukemia
NCT00002844Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 1991
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 1991; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
chronic lymphocytic leukemia (CLL)prolymphocytic leukemia (PLL)
Beyond the preview
Go deeper on NCT00002844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002844.